Growth Metrics

ENDRA Life Sciences (NDRA) Gross Margin: 2016-2018

Historic Gross Margin for ENDRA Life Sciences (NDRA) over the last 2 years, with Mar 2018 value amounting to 100.00%.

  • ENDRA Life Sciences' Gross Margin was N/A to 100.00% in Q1 2018 from the same period last year, while for Mar 2018 it was 51.71%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q1 2018, ENDRA Life Sciences' Gross Margin stood at 100.00%, which was up 81.94% from 54.96% recorded in Q4 2017.
  • ENDRA Life Sciences' 5-year Gross Margin high stood at 100.00% for Q2 2016, and its period low was 10.98% during Q2 2017.
  • Its 3-year average for Gross Margin is 68.43%, with a median of 58.79% in 2017.
  • Data for ENDRA Life Sciences' Gross Margin shows a peak YoY increase of 71bps (in 2017) and a maximum YoY decrease of 8,902bps (in 2017) over the last 5 years.
  • Quarterly analysis of 3 years shows ENDRA Life Sciences' Gross Margin stood at 54.25% in 2016, then skyrocketed by 71bps to 54.96% in 2017, then reached 100.00% in 2018.
  • Its Gross Margin stands at 100.00% for Q1 2018, versus 54.96% for Q4 2017 and 58.79% for Q3 2017.